DIVIDEND ANNOUNCEMENT: 8.625% Sr Nt 04/30/2026/Harrow Health Inc (NASDAQ:HROWL) on 04/03/2024 declared a dividend of $0.5391 per share

8.625% Sr Nt 04/30/2026/Harrow Health Inc (NASDAQ:HROWL) on 04/03/2024 declared a dividend of $ 0.5391 per share payable on April 30, 2024 to shareholders of record as of April 15, 2024.

8.625% Sr Nt 04/30/2026/Harrow Health Inc (NASDAQ:HROWL) has paid dividends since 2021, has a current dividend yield of 8.6365451813% and has increased its dividends for 0 successive years.

The stock price closed yesterday at $ 25.01 and has a 52 week low/high of $ 22.05 and $ 25.25.

Harrow Health is an ophthalmic-focused pharmaceutical company. Co. engages in the development, production, sale and distribution of prescription medications. Co. owns and operates ImprimisRx, the ophthalmology-focused pharmaceutical-compounding business, and its branded drugs are marketed under its Harrow name. In addition, Co. also has non-controlling equity positions in Surface Ophthalmics, Inc., which is focused on development and commercialization of therapeutics for ocular surface diseases; and Melt Pharmaceuticals, Inc., which is focused on the development and commercialization of proprietary non-intravenous, sedation and anesthesia therapeutics for human medical procedures.

For more information on 8.625% Sr Nt 04/30/2026/Harrow Health Inc click here.